Tohoku University Venture Partners, JIC Venture Growth Investments, Astellas Venture Management LLC, and eight other companies, as well as an AMED grant, raised a total of approximately 1.5 billion yen in Series B round funding.
Toregem has raised a total of approximately JPY 1.5 billion in funding through a third-party allotment of new shares (Series B) and a grant from the 2024 “Drug Discovery Venture Ecosystem Enhancement Project (Drug Discovery Venture Open Call)” (4th round) of the National Institute for Medical Research and Development (AMED). With this funding, the company […]
Speaker at ‘Initiatives to Change Japan from Tohoku University - Tohoku University Science Park Initiative and the Creation of an Innovation Ecosystem through University Start-ups - FEATURED BY KPMG’.
Speaker at ‘Initiatives to Change Japan from Tohoku University - Tohoku University Science Park Initiative and Creation of Innovation Ecosystem by University Start-ups - FEATURED BY KPMG’, held on 28 August 2024. Speaker at ‘Initiatives to Change Japan from Tohoku University - Tohoku University Science Park Initiative and Innovation Ecosystem Creation by University Start-ups - […]
The President's Award of the Japan Venture Society was awarded in the “University Venture Award 2024 - AWARD FOR ACADEMIC STARTUPS”.
22 Aug 2024 The company received the President's Award of the Japan Venture Society at the ‘Award for University Ventures 2024 - AWARD FOR ACADEMIC STARTUPS’. Toregem was awarded the Chairman's Prize of the Japan Venture Society at the “Award for University-Launched Ventures 2024 - Award for Academic Startups” organised by the National Science and […]
Award for Excellence in Presentation at the KPMG GLOBAL TECH INNOVATOR COMPETITION IN JAPAN 2024.
The presentation excellence award at the KPMG Global Tech Innovator Competition in Japan 2024, organised by KPMG Private Enterprise.
Our project was selected for the AMED “Drug Discovery Venture Ecosystem Enhancement Project”.
The Japan Agency for Medical Research and Development (AMED) has selected us as an implementing organisation for the 4th ‘Drug Discovery Venture Ecosystem Enhancement Project (Drug Discovery Venture Open Call)’ in 2024.We will take this opportunity to further accelerate the development of tooth regeneration therapies. Subsidised project subject: Development of a novel antibody medicine to […]